PepGen Inc. (PEPG)
4.64
+2.25
(+94.14%)
USD |
NASDAQ |
Nov 10, 16:00
5.18
+0.54
(+11.64%)
After-Hours: 20:00
PepGen Cash from Operations (Annual) : -81.64M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -81.64M |
| December 31, 2024 | -82.37M |
| December 31, 2023 | -69.00M |
| December 31, 2022 | -59.26M |
| Date | Value |
|---|---|
| December 31, 2021 | -22.60M |
| December 31, 2020 | -1.652M |
| December 31, 2019 | -0.885M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Korsana Biosciences, Inc. | -3.314M |
| IRulya Therapeutics, Inc. | -41.42M |
| Q32 Bio, Inc. | -33.54M |
| Bridgebio Oncology Therapeutics, Inc. | -113.89M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |